跳至主要内容
临床试验/NCT03017560
NCT03017560已完成不适用

Treating Verbal Memory Deficits Following Chemotherapy for Breast Cancer

Northwestern University0 个研究点目标入组 45 人开始时间: 2015年12月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
45
主要终点
Verbal Memory

研究概览

简要总结

The primary purpose of this study is to test the effects of a targeted, computerized cognitive training program on verbal memory in older women who have undergone chemotherapy treatment for early-stage breast cancer. As measured by neuropsychological assessment, this treatment will result in improved verbal memory. Secondarily, processing speed and naming abilities are expected to improve. Enhanced self-perception of cognitive ability is also expected.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
65 Years 至 90 Years(Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women ages 65-90
  • Chemotherapy treatment for early-stage (I, IIa, IIb, IIIa) breast cancer
  • Post-menopausal
  • High school education or greater
  • Geographically available for followup assessment
  • Native English speaker
  • Normal or corrected to near-normal hearing and vision

排除标准

  • Psychiatric history including past or current psychotic spectrum disorders (schizophrenia, bipolar disorder, major depressive disorder, dementia, schizoaffective disorder)
  • Brain injury (e.g., stroke, heart attack, aneurysm, tumor, concussion, head trauma)
  • Brain disease
  • History of brain irradiation or surgery
  • Current or past disease/disorder of the central nervous system or medical condition affecting cognitive functioning (e.g., chronic migraine, epilepsy or history of seizures, encephalitis, meningitis, multiple sclerosis, thyroid condition, Parkinson's, Alzheimer's, Huntington's disease)
  • Active diagnosis of autoimmune or inflammatory disorder (e.g., systemic lupus erythematosus, rheumatoid arthritis, vasculitis, insulin-dependent diabetes, Crohn's disease, uncontrolled allergic reaction or asthma)
  • History of other cancer, except for basal cell carcinoma
  • Development of a second primary malignancy during the study
  • Drug or alcohol abuse (i.e., more than 7 drinks per week)
  • Chronic use of oral steroid medication
  • Former (prior to early-stage breast cancer) intrathecal therapy, radiation therapy, chemotherapy, or any neoadjuvant chemotherapy
  • Acquired or developmental speech, language, or learning disorders (e.g., aphasia, dyslexia, dysgraphia, auditory processing disorder, autism, developmental delay)
  • Hormone replacement therapy, excluding vaginal estrogen

结局指标

主要结局

Verbal Memory

时间窗: Change in Verbal Memory scores from Pretreatment/Baseline to Posttreatment/6 weeks, from Posttreatment/6 weeks to 1 month followup/10 weeks, and from Pretreatment/Baseline to 1 month followup/10 weeks.

Immediate and delayed verbal memory

次要结局

  • Processing Speed measured via Lexical Decision Task(Change in Processing Speed scores from Pretreatment/Baseline to Posttreatment/6 weeks, from Posttreatment/6 weeks to 1 month followup/10 weeks, and from Pretreatment/Baseline to 1 month followup/10 weeks)
  • Processing Speed measured via Stroop Color-Word Test(Change in Processing Speed scores from Pretreatment/Baseline to Posttreatment/6 weeks, from Posttreatment/6 weeks to 1 month followup/10 weeks, and from Pretreatment/Baseline to 1 month followup/10 weeks)

研究者

申办方类型
Other
责任方
Sponsor

相似试验

Treating Verbal Memory Deficits Following... | 临床试验